Retrope, Inc., a privately held clinical-stage pharmaceutical company leading the advance of a revolutionary new unifying theory of aging and degeneration,…
Articles by Margarida Azevedo, MSc
Gene-therapy specialist company, AAVLife, recently acquired a patent from the United States Patent and Trademark Office for an experimental treatment…
The Friedrich’s Ataxia Research Alliance (FARA), a non-profit organization that supports scientific research aimed at finding treatments and a cure for…
Horizon Pharma has recently announced it initiated a Phase 3 study evaluating the Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in…
The Research Acceleration and Innovation Network (TRAIN) has invited nonprofit organization Friedreich’s Ataxia Research Alliance (FARA), which works…
Specialty biopharmaceutical Horizon Pharma plc has been awarded Fast Track status from the U.S. Food and Drug…
In a recent article titled “Consensus clinical management guidelines for Friedreich ataxia” published in the journal…
Intrexon Corporation has made an offer for the total acquisition of Exemplar Genetics, which is a company dedicated to…
Specialty biopharmaceutical company Horizon Pharma plc has released a business update on its primary care and orphan divisions,…
A new study on Friedreich’s Ataxia entitled “Sensitivity of Spatiotemporal Gait Parameters in Measuring Disease Severity in…